{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:41:12Z","timestamp":1790808072892,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T00:00:00Z","timestamp":1655251200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ijid.2022.06.025","type":"journal-article","created":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T11:26:38Z","timestamp":1655551598000},"page":"375-381","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Treatment outcome of imported cutaneous leishmaniasis among travelers and migrants infected with Leishmania major and Leishmania tropica: a retrospective study in European centers 2013 to 2019"],"prefix":"10.1016","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7401-2245","authenticated-orcid":false,"given":"Hedvig","family":"Glans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leif","family":"Dotevall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert","family":"Van der Auwera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldert","family":"Bart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Blum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Buffet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9129-7799","authenticated-orcid":false,"given":"Romain","family":"Guery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Gangneux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6627-0474","authenticated-orcid":false,"given":"Saskia","family":"van Henten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gundel","family":"Harms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Varani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4493-596X","authenticated-orcid":false,"given":"Florence","family":"Robert-Gangneux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6494-6466","authenticated-orcid":false,"given":"Robert","family":"Rongisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4624-0259","authenticated-orcid":false,"given":"Bj\u00f6rn","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2022.06.025_bib0001","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003687","article-title":"Phlebotomus sergenti in a cutaneous leishmaniasis focus in Azilal province (High Atlas, Morocco): molecular detection and genotyping of Leishmania tropica, and feeding behavior","volume":"9","author":"Ajaoud","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ijid.2022.06.025_bib0002","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1365-4632.2007.03154.x","article-title":"Clinical manifestations and classification of Old World cutaneous leishmaniasis","volume":"46","author":"Akilov","year":"2007","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ijid.2022.06.025_bib0003","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3201\/eid2205.160042","article-title":"Cutaneous leishmaniasis and conflict in Syria","volume":"22","author":"Al-Salem","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijid.2022.06.025_bib0004","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMoa011882","article-title":"Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major","volume":"346","author":"Alrajhi","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2022.06.025_bib0005","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-4632.2004.02002.x","article-title":"Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (glucantime) vs. cryotherapy and intralesional meglumine antimoniate (glucantime) alone for the treatment of cutaneous leishmaniasis","volume":"43","author":"Asilian","year":"2004","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ijid.2022.06.025_bib0006","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.clindermatol.2006.05.008","article-title":"Cutaneous leishmaniasis","volume":"25","author":"Bailey","year":"2007","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.ijid.2022.06.025_bib0007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009089","article-title":"Major risk factors and histopathological profile of treatment failure, relapse and chronic patients with anthroponotic cutaneous leishmaniasis: a prospective case-control study on treatment outcome and their medical importance","volume":"15","author":"Bamorovat","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ijid.2022.06.025_bib0008","doi-asserted-by":"crossref","first-page":"20544","DOI":"10.2807\/1560-7917.ES2013.18.30.20544","article-title":"Imported leishmaniasis in the Netherlands from 2005 to 2012: epidemiology, diagnostic techniques and sequence-based species typing from 195 patients","volume":"18","author":"Bart","year":"2013","journal-title":"Euro Surveill"},{"key":"10.1016\/j.ijid.2022.06.025_bib0009","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJMoa1202657","article-title":"Topical paromomycin with or without gentamicin for cutaneous leishmaniasis","volume":"368","author":"Ben Salah","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2022.06.025_bib0010","doi-asserted-by":"crossref","first-page":"e2749","DOI":"10.1371\/journal.pntd.0002749","article-title":"Parasite load decrease during application of a safe and easily applied antileishmanial aminoglycoside cream","volume":"8","author":"Ben Salah","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ijid.2022.06.025_bib0011","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/jtm.12089","article-title":"LeishMan recommendations for treatment of cutaneous and mucosal leishmaniasis in travelers, 2014","volume":"21","author":"Blum","year":"2014","journal-title":"J Travel Med"},{"key":"10.1016\/j.ijid.2022.06.025_bib0012","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/jac\/dkh058","article-title":"Treatment of cutaneous leishmaniasis among travellers","volume":"53","author":"Blum","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2022.06.025_bib0013","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1708-8305.2008.00286.x","article-title":"Treatment of cutaneous leishmaniasis in travelers 2009","volume":"16","author":"Blum","year":"2009","journal-title":"J Travel Med"},{"key":"10.1016\/j.ijid.2022.06.025_bib0014","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taz055","article-title":"GeoSentinel Surveillance Network. Cutaneous and mucocutaneous leishmaniasis in travellers and migrants: a 20-year GeoSentinel Surveillance Network analysis","volume":"26","author":"Boggild","year":"2019","journal-title":"J Travel Med"},{"key":"10.1016\/j.ijid.2022.06.025_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184777","article-title":"Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: a systematic review","volume":"12","author":"Brito","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2022.06.025_bib0016","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/bjd.12205","article-title":"Long-term efficacy of single-dose radiofrequency-induced heat therapy vs. intralesional antimonials for cutaneous leishmaniasis in India","volume":"168","author":"Bumb","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ijid.2022.06.025_bib0017","first-page":"253","article-title":"Current status of cutaneous leishmaniasis in Aleppo, Syrian Arab Republic","volume":"75","author":"Douba","year":"1997","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.ijid.2022.06.025_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004545","article-title":"Old World cutaneous leishmaniasis and refugee crises in the Middle East and North Africa","volume":"10","author":"Du","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ijid.2022.06.025_bib0019","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/0035-9203(90)90146-6","article-title":"A double-blind clinical trial of the treatment of cutaneous leishmaniasis with paromomycin ointment","volume":"84","author":"el-Safi","year":"1990","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.ijid.2022.06.025_bib0020","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jaad.2010.04.014","article-title":"Superior efficacy of oral fluconazole 400 mg daily versus oral fluconazole 200 mg daily in the treatment of cutaneous leishmania major infection: a randomized clinical trial","volume":"64","author":"Emad","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ijid.2022.06.025_bib0021","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1128\/AAC.35.6.1208","article-title":"Comparative pharmacokinetics of amphotericin B after administration of a novel colloidal delivery system, ABCD, and a conventional formulation to rats","volume":"35","author":"Fielding","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2022.06.025_bib0022","first-page":"538","article-title":"Topical treatment for cutaneous leishmaniasis","volume":"3","author":"Garnier","year":"2002","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.ijid.2022.06.025_bib0023","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1186\/s12879-018-3539-1","article-title":"Cutaneous, mucocutaneous and visceral leishmaniasis in Sweden from 1996\u20132016: a retrospective study of clinical characteristics, treatments and outcomes","volume":"18","author":"Glans","year":"2018","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijid.2022.06.025_bib0024","article-title":"Interventions for Old World cutaneous leishmaniasis","volume":"4","author":"Gonz\u00e1lez","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijid.2022.06.025_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006094","article-title":"French Cutaneous Leishmaniasis Study group & the LeishMan network. Liposomal amphotericin B in travelers with cutaneous and muco-cutaneous leishmaniasis: not a panacea","volume":"11","author":"Guery","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ijid.2022.06.025_bib0026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009863","article-title":"LeishMan Network and the French Cutaneous Leishmaniasis Study group. Clinical diversity and treatment results in tegumentary leishmaniasis: a European clinical report in 459 patients","volume":"15","author":"Guery","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ijid.2022.06.025_bib0027","doi-asserted-by":"crossref","first-page":"e2832","DOI":"10.1371\/journal.pntd.0002832","article-title":"Species-directed therapy for leishmaniasis in returning travellers: a comprehensive guide","volume":"8","author":"Hodiamont","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ijid.2022.06.025_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008988","article-title":"Effectiveness of miltefosine in cutaneous leishmaniasis caused by Leishmania tropica in Pakistan after antimonial treatment failure or contraindications to first line therapy-A retrospective analysis","volume":"15","author":"K\u00e4mink","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ijid.2022.06.025_bib0029","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.actatropica.2019.04.005","article-title":"Cutaneous leishmaniasis among Syrian refugees in Jordan","volume":"194","author":"Kanani","year":"2019","journal-title":"Acta Trop"},{"issue":"Suppl. 1","key":"10.1016\/j.ijid.2022.06.025_bib0030","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/eurpub\/cku105","article-title":"Emigration flows from North Africa to Europe","volume":"24","author":"Kassar","year":"2014","journal-title":"Eur J Public Health"},{"issue":"35","key":"10.1016\/j.ijid.2022.06.025_bib0031","first-page":"e1","article-title":"Treatment of acute Old World cutaneous leishmaniasis: a systematic review of the randomized controlled trials","volume":"57","author":"Khatami","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ijid.2022.06.025_bib0032","first-page":"544","article-title":"Clinical features of anthroponotic cutaneous leishmaniasis in a major focus, Southeastern Iran, 1994\u20132014","volume":"12","author":"Khosravi","year":"2017","journal-title":"Iran J Parasitol"},{"key":"10.1016\/j.ijid.2022.06.025_bib0033","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4269\/ajtmh.2009.80.172","article-title":"Efficacy of cryotherapy versus intralesional Meglumine Antimoniate (glucantime) for treatment of cutaneous leishmaniasis in children","volume":"80","author":"Layegh","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ijid.2022.06.025_bib0034","first-page":"27","article-title":"Cutaneous leishmaniasis in refugees from Syria: complex cases in Berlin 2015\u20132020","author":"Lindner","year":"2020","journal-title":"J Travel Med"},{"key":"10.1016\/j.ijid.2022.06.025_bib0035","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s12879-016-1663-3","article-title":"Efficacy of cryotherapy for the treatment of cutaneous leishmaniasis: meta-analyses of clinical trials","volume":"16","author":"L\u00f3pez-Carvajal","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijid.2022.06.025_bib0036","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.tmaid.2006.09.004","article-title":"Cutaneous leishmaniasis treatment","volume":"5","author":"Minodier","year":"2007","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.ijid.2022.06.025_bib0037","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.actatropica.2007.05.005","article-title":"Comparison of miltefosine and meglumine antimoniate for the treatment of zoonotic cutaneous leishmaniasis (ZCL) by a randomized clinical trial in Iran","volume":"103","author":"Mohebali","year":"2007","journal-title":"Acta Trop"},{"key":"10.1016\/j.ijid.2022.06.025_bib0038","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/cid\/cit269","article-title":"Cutaneous Leishmaniasis French Study Group. Travelers with cutaneous leishmaniasis cured without systemic therapy","volume":"57","author":"Morizot","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2022.06.025_bib0039","doi-asserted-by":"crossref","first-page":"ofw008","DOI":"10.1093\/ofid\/ofw008","article-title":"Miltefosine for mucosal and complicated cutaneous Old World leishmaniasis: a case series and review of the literature","volume":"3","author":"Mosimann","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijid.2022.06.025_bib0040","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jaad.2007.12.032","article-title":"Efficacy of a weekly cryotherapy regimen to treat Leishmania major cutaneous leishmaniasis","volume":"58","author":"Mosleh","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ijid.2022.06.025_bib0041","series-title":"Guidelines for the treatment and prevention of cutaneous leishmaniasis in Pakistan","author":"Munir","year":"2002"},{"key":"10.1016\/j.ijid.2022.06.025_bib0042","doi-asserted-by":"crossref","first-page":"e2130","DOI":"10.1371\/journal.pntd.0002130","article-title":"Methodology of clinical trials aimed at assessing interventions for cutaneous leishmaniasis","volume":"7","author":"Olliaro","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ijid.2022.06.025_bib0043","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/trstmh\/tru011","article-title":"Liposomal formulation of amphotericin B for the treatment of mucosal leishmaniasis in HIV-negative patients","volume":"108","author":"Rocio","year":"2014","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.ijid.2022.06.025_bib0044","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1371\/journal.ppat.0030091","article-title":"Leishmania manipulation of sand fly feeding behavior results in enhanced transmission","volume":"3","author":"Rogers","year":"2007","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ijid.2022.06.025_bib0045","first-page":"11","article-title":"Lipsosomal amphotericin B: a review of its properties, function, and use for treatment of cutaneous leishmaniasis","volume":"10","author":"Shirzadi","year":"2019","journal-title":"Res Rep Trop Med"},{"key":"10.1016\/j.ijid.2022.06.025_bib0046","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1468-3083.2010.03908.x","article-title":"Liposomal amphotericin B treatment of cutaneous leishmaniasis due to Leishmania tropica","volume":"25","author":"Solomon","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ijid.2022.06.025_bib0047","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jaad.2012.06.014","article-title":"Liposomal amphotericin B in comparison to sodium stibogluconate for Leishmania braziliensis cutaneous leishmaniasis in travelers","volume":"68","author":"Solomon","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ijid.2022.06.025_bib0048","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1086\/591972","article-title":"New treatment approach in Indian visceral leishmaniasis: single-dose liposomal amphotericin B followed by short-course oral miltefosine","volume":"47","author":"Sundar","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2022.06.025_bib0050","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.4269\/ajtmh.2010.10-0143","article-title":"Cutaneous leishmaniasis (Leishmania major infection) in Dutch troops deployed in northern Afghanistan: epidemiology, clinical aspects, and treatment","volume":"83","author":"Van Thiel","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ijid.2022.06.025_bib0051","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1086\/648726","article-title":"Miltefosine treatment of Leishmania major infection: an observational study involving Dutch military personnel returning from northern Afghanistan","volume":"50","author":"van Thiel","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2022.06.025_bib0052","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02009-17","article-title":"Relation between skin pharmacokinetics and efficacy in AmBisome treatment of murine cutaneous leishmaniasis","volume":"62","author":"Wijnant","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2022.06.025_bib0053","first-page":"43","article-title":"Cutaneous and presumed visceral leishmaniasis in a soldier deployed to Afghanistan","volume":"8","author":"Woodrow","year":"2006","journal-title":"MedGenMed"},{"key":"10.1016\/j.ijid.2022.06.025_bib0054","series-title":"Control of the leishmaniases. WHO Technical Report Series 949","first-page":"1","year":"2010"},{"key":"10.1016\/j.ijid.2022.06.025_bib0055","series-title":"Manual for case management of cutaneous leishmaniasis in the WHO eastern Mediterranean Region","year":"2014"},{"key":"10.1016\/j.ijid.2022.06.025_bib0056","first-page":"287","article-title":"Leishmaniasis in high-burden countries: an epidemiological update based on data reported in 2014","volume":"91","year":"2016","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.ijid.2022.06.025_bib0057","first-page":"557","article-title":"Global leishmaniasis update, 2006\u20132015: a turning point in leishmaniasis surveillance","volume":"92","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.ijid.2022.06.025_bib0049","unstructured":"United Nations High Commission for Refugees, Mid-Years Trends 2017. URL, https:\/\/www.unhcr.org\/5aaa4fd27.pdf (accessed 26 June 2022)."}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971222003605?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971222003605?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T10:34:01Z","timestamp":1715423641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971222003605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":57,"alternative-id":["S1201971222003605"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2022.06.025","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment outcome of imported cutaneous leishmaniasis among travelers and migrants infected with Leishmania major and Leishmania tropica: a retrospective study in European centers 2013 to 2019","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2022.06.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}